-
Citi Downgrades Watson Pharmaceuticals (WPI) to Neutral
-
Viking Global Shows New Stakes In Apple (AAPL), Citi (C); Sells Out of JPMorgan (JPM), Morgan Stanley (MS)
-
Viking Global Shows New Stakes In Media Cos Viacom (VIA) and News Corp (NWS), Also Shows New Stake in Wells Fargo (WFC)
-
Citi on Generic Pharmaceuticals: Multiple Compression Overdone
-
Citi Reiterates a 'Buy' Rating on Watson Pharmaceuticals (WPI); Expect a Positive Outcome from FDA AdCom on Ulipristal(UPA)
-
Citi Reiterates a 'Buy' on Teva Pharmaceutical (TEVA); Generic Yaz Launch Adds Upside Pressure to Earnings
-
Citi Reiterates a 'Buy' on WPI, TEVA & MYL After Generic Approval of VALTREX
-
Citi Reiterates a 'Buy' on Teva & Watson Pharma After Canadian Approval of Generic Lipitor
-
Citi Reiterates a 'Buy' on Watson Pharmaceuticals (WPI); 1Q10 Post View: Maintaining Our Above Consensus EPS Estimates
-
Citi Reiterates a 'Buy' on Watson Pharmaceuticals (WPI); 1Q10 Preview: We Expect Outperformance
-
Citi Isues 1Q10 Earnings Preview on Generic Pharmaceuticals -Outperformance Expected
-
Citi Reiterates a 'Buy' on Watson Pharmaceuticals (WPI); Thoughts on Generic Toprol XL 100/200mg Approval
-
Citi Upgrades Watson Pharmaceuticals (WPI) to Buy
-
David Moenning's Daily State of the Markets: 4/30
-
David Moenning's Daily State of the Markets: 2/19
-
Notable Analyst Rating Changes 2/17: CHA, GLW, MAR, HOT Upgraded; LYG, DE, GOOG, DEO Downgraded
-
Citi Initiates Coverage on Watson Pharmaceuticals (WPI) with a Hold
-
David Moenning's Daily State of the Markets: 9/16
-
Matrix USA Rating Changes 3/4